IL6 and COVID-19: Hyperbaric oxygen treatment reduces the expression of L-1β, IL-6, and TNF-α, was shown to be effective in the treatment of radiation injury [192] and wound-healing [193], and has been proposed as a treatment option to prevent the development of post-COVID-19 fibrosis [194].